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Introduction 
Stress urinary incontinence (SUI) affects a large pro-
portion of middle-aged and elderly women, consider-
ably lowering their quality of life and causing major
economical costs to the society. When all conservative
means are ineffective, a surgical treatment is contem-
plated, including retropubic suspension, pubovaginal
and tension-free slings. Tension-free tapes are consid-
ered as minimally invasive procedures, yielding a lesser
degree of discomfort and a faster return to normal daily
activities for the patients, who nevertheless still require
surgery, troncular anesthesia, and an overnight hospital
stay in most cases.
Emphasis on minimally invasive options for the sur-
gical treatment of SUI as an alternative to the men-
tioned surgical procedures has resulted in the develop-
ment of agents and techniques that substantially im-
prove these conditions towards social continence, but
currently give suboptimal cure/dry rates. The applica-
tion of injectable therapies as compelling procedures
implies the potential for cost-efficient treatment for se-
lected patients with urinary incontinence. A number of
different substances have been used and reported to be
safe and effective in the peer reviewed literature includ-
ing: bovine glutaraldehyde cross linked (GAX) colla-
gen, polytetrafluoroethylene (Teflon), polydimethyl-
siloxane elastomer (silicon), carbon coated zirconium
beads, hyaluronic acid/dextranomer, and autologous
tissues such as fat and cartilage (1). At present, there is
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no current evidence suggesting that any of the available
periurethral injectables is superior to others with re-
spect to efficacy, durability or safety. This treatment
may be offered to women with urodynamic stress uri-
nary incontinence, wishing to avoid the complications
associated with more invasive surgery, on the basis of low
operative morbidity and low long-term success rates. 
These substances may be injected by a retrograde
(more common) or anterograde technique in the peri-
urethral tissue around the bladder neck and proximal
urethra.
Which kind of anesthetic technique? 
If we consider scientific literature, most authors do
not pay much attention to the anesthetic technique
during this manoeuvre, stating that it may be per-
formed either under general or local anesthesia, accord-
ing to the surgeon’s preference. 
The choice of the anesthetic technique depends
on the following factors: 
– Anesthetist’s preference and ability; 
– Patient’s safety (physical conditions, kind of
surgery);
– Patient’s preference; 
– Surgeon’s preference. 
There are three main types of anesthetic techniques:
general, loco-regional and local anesthesia.
As per the loco-regional anesthesia, there are two
main central techniques: peridural and subarachnoid.
Table I shows the main characteristics of these two
kinds of central loco-regional techniques.
The advantages of both the loco-regional and
local anesthesia versus the general one are as
follows:
– decrease in the surgical stress for patient’s organism
through the block of the nociceptive afferences, with
reduced neuroendocrine and metabolic answers;
– compliance on the patient’s part;
- improvement of respiratory performance in the
postoperative period;
– less cardio-circulatory involvement; 
– fewer thrombo-embolic complications; 
– less incidence of side effects (nausea, vomiting,
drowsiness, pain); 
– better control of pain in the postoperative period;
– possibility of avoiding complications linked to gen-
eral anesthesia (difficult intubation, ab ingestis pneu-
monia; malignant hyperthermia; technical accidents
such as hypoxia; cardiac arrest; pollution of the surgical
theatre by gas);
– shorter hospitalization time;
– lower costs.
The disadvantages of loco-regional anesthesia
are: 
– necessity of anesthetist’s good experience and tech-
nique;
– not always perfect analgesia in relation to the opera-
tive time.
Loco-regional anesthesia is contraindicated in the fol-
lowing conditions:
– patient who does not want this kind of anesthesia
or he/she is not compliant; 
– cutaneous infections or sepsis; 
– severe hypotension, shock; 
– coagulation defects; 
– spinal cord and peripheral neurogenic diseases
(neuropathies, multiple sclerosis, amyotrophic lateral
sclerosis); 
– well-known allergy to local anesthetics;
– anatomical malformations. 
Local anesthetics may be responsible for the follow-
ing systemic and local complications:
a) systemic 
– CNS toxicity (paraesthesia in the mouth; tremors;
convulsions; coma);
– cardiac toxicity (decreased inotropism; bradycardia;
arrhythmia; atrium-ventricular block; ventricular fibril-
lation);
– allergic reactions;
– vaso-vagal reactions;
– moderate/severe hypotension; 
b) local 
– nervous fibers lesions (mechanical/chemical); 
– infections at the anesthesia site;
– hematoma;
TABLE I - CHARACTERISTICS OF CENTRAL LOCO-
REGIONAL ANESTHETIC TECHNIQUES 
Characteristics Subarachnoid Peridural
Technical simplicity Yes No 
Systemic toxicity No Possible 
Cardiovascular stability Variable Good 
Outcome predictability Yes Variable 
Analgesia quality Good Variable 
Headache Possible No 
Topographic selectivity Yes Variable 
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– post-spinal cephalea; 
– complications due to spinal/peridural anesthesia.
When the operator chooses local anesthesia, after
placing the female patient in the lithotomy position,
the introitus and urethra may be anesthetized with top-
ical 2% lidocaine gel or 2.5% lidocaine – 2.5% prilo-
caine cream (EmlaTM) for 10 minutes. After that, a 1%
lidocaine solution may be administered through a peri-
urethral or transurethral route of injection, as addition-
al anesthesia, in different sites of the urethra. Should
collagen be used, the anesthetic solution is infiltrated
periurethrally in the 4 and 8 o’clock positions on each
side of the urethra for a total of approximately 4ml on
each side (2). In case of polydimethylsiloxane infiltra-
tion, the anesthetic solution may be injected into the
urethra at the six, ten and two o’clock positions, 1.5 to
2cm distal from the bladder neck (3), in the same posi-
tions where the bulking agent is infiltrated afterwards
(3). Madjar et al described an anesthetic technique
used to implant Durasphere (nonabsorbable, pyrolytic,
carbon coated zirconium oxide beads suspended in
2.8% glucan as a carrier gel), transurethrally (4). This
procedure is carried out using local anesthesia with in-
traurethral application of 1% lidocaine hydrochloride
jelly; following a routine video-monitored cystoscopy,
the bladder is completely drained. The cystoscope is
withdrawn to the distal urethra in order to simultaneous-
ly view the bladder neck, mid and proximal urethra. A
needle is introduced through the cystoscopic sheath and
directed at 45 degrees to the lumen, and into the urethral
wall at the 4 o’clock position (left hand dominant sur-
geons may find the 8 o’clock position preferable). After
the needle tip penetrates the urethra wall and the bevel is
no longer seen, it is advanced, parallel to the urethra lu-
men, for 1 to 2 cm. At this point, 1.5 mL 1% lidocaine
solution are injected into the submucosal layer. This step
results in partial coaptation of the urethral walls and hy-
drodissection of the space where the beads are eventually
injected (4). 
During the transurethral injection of non-animal-stabi-
lized hyaluronic acid/dextranomer (NASHA/Dx) copoly-
mer, it may be enough to put an anesthetic jelly
transurethrally for approximately 10 minutes (i.e., 5 mg
of EmlaTM cream), and to start then with the injection
manoeuvres according to the manufacturer’s guidelines
(5). 
Conclusions 
The anesthetic techniques employed during peri-
urethral and/or transurethral bulking agents injection
are not well documented in literature. There are no
studies comparing the different types of anesthetic
techniques, and the administration of general and/or
local anesthesia usually depends exclusively on the in-
vestigator’s preference; moreover, it is often not clear if
different anesthetic techniques have been performed in
the same report. The use of local anesthesia certainly
could allow performing this minimally invasive proce-
dure in an office-setting reducing costs. Nevertheless,
there are no evidences supporting this hypothesis. 
Future studies comparing different anesthetic tech-
niques could allow us to choose the most cost-effective
anesthetic procedure aiming at enhancing both the pa-
tient’s health and the intervention effectiveness and
safety. 
Riassunto
Gli agenti volumizzanti iniettati per via retrograda o
anterograda nel tessuto periuretrale attorno al collo ve-
scicale, o a livello dell’uretra prossimale, rappresentano
una opzione terapeutica alternativa a procedure chirur-
giche più invasive per il management dell’incontinenza
urinaria da sforzo. Poiché tale approccio terapeutico
potrebbe essere fatto sia ambulatorialmente che in regi-
me di Day Surgery, grande importanza assume la tecni-
ca anestesiologica impiegata durante tale procedura. La
scelta del tipo di tecnica anestesiologica da impiegare
(generale, loco-regionale, locale) dipenderà da diversi
fattori quali le preferenze e l’abilità dell’anestesista, la
sicurezza e la preferenza del paziente, la preferenza del
chirurgo. Le tecniche anestesiologiche impiegate duran-
te l’iniezione periuretrale e/o transuretrale di agenti vo-
lumizzanti (“bulking agents”) non sono ben documen-
tate in letteratura. Non vi sono studi che confrontino i
differenti tipi di tecnica anestesiologica, e la sommini-
strazione di una anestesia generale e/o locale solitamen-
te dipende esclusivamente dalle preferenze dell’operato-
re e spesso non è chiaro se nello stesso report vengano
eseguiti contemporaneamente più tipi di anestesia.
L’impiego di una anestesia locale certamente potrebbe
rendere possibile l’esecuzione ambulatoriale della pro-
cedura riducendo i costi. Tuttavia non vi sono evidenze
che supportino tale ipotesi. Sono necessari ulteriori stu-
di che mettano a confronto le differenti tecniche ane-
stesiologiche al fine di poter scegliere la procedura ane-
stesiologica con il miglior rapporto costo-beneficio. 
Gli Autori dichiarano che la ricerca riportata nel loro lavoro è stata esegui-
ta nel rispetto della Dichiarazione di Helsinki e dei principi internaziona-
li che regolano la ricerca sugli animali. 
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